Literature DB >> 3197094

The effect of metoclopramide and prochlorperazine on the absorption of effervescent paracetamol in migraine.

R A Tokola1.   

Abstract

Antiemetics modify gastric emptying, a rate-limiting step in drug absorption. The absorption of effervescent paracetamol in water solution was studied in three groups of 10 female patients during acute migraine attacks. Paracetamol was preceded 30 min earlier by a rectal dose of metoclopramide, prochlorperazine maleate, or placebo. Each patient was retested with paracetamol when headache-free. Migraine attacks delayed slightly the absorption of paracetamol solution. Prior administration of rectal prochlorperazine had a minor delaying effect on paracetamol absorption. The peak concentration, the time to reach the peak, and the area under the time-concentration curve from 0 to 6 h of paracetamol were similar with the three treatments.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197094     DOI: 10.1046/j.1468-2982.1988.0803113.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  6 in total

1.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

2.  New Prescriptions for Migraine in the Emergency Department: Treating a common affliction and presenting symptom.

Authors:  P L Lane
Journal:  Can Fam Physician       Date:  1992-06       Impact factor: 3.275

Review 3.  Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine.

Authors:  Alan M Rapoport; Fred Freitag; Starr H Pearlman
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

4.  Remarks on an educational training course on headache.

Authors:  G Casucci; V Villani; F Frediani
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

5.  Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.

Authors:  Richard B Lipton; Pete Schmidt; Hans-Christoph Diener
Journal:  Headache       Date:  2017-04-06       Impact factor: 5.887

Review 6.  Optimal management of severe nausea and vomiting in migraine: improving patient outcomes.

Authors:  Miguel Ja Láinez; Ana García-Casado; Francisco Gascón
Journal:  Patient Relat Outcome Meas       Date:  2013-10-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.